E-cadherin Produits
(Cadherin 1, Type 1, E-Cadherin (Epithelial) (CDH1))
Catégories
This gene is a classical cadherin from the cadherin superfamily. The encoded protein is a calcium dependent cell-cell adhesion glycoprotein comprised of five extracellular cadherin repeats, a transmembrane region and a highly conserved cytoplasmic tail. Mutations in this gene are correlated with gastric, breast, colorectal, thyroid and ovarian cancer. Loss of function is thought to contribute to progression in cancer by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells and the cytoplasmic domain is required for internalization. Identified transcript variants arise from mutation at consensus splice sites. [provided by RefSeq, Jul 2008].
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
Catégories E-cadherin en vedette
E-cadherin Anticorps
High quality antibodies with extensive validation data.
E-cadherin Kits ELISA
Reliable ELISA kits for a wide range of species.
E-cadherin Protéines
Proteins for various applications incl. WB, ELISA, IF etc.
E-cadherin recommandé Anticorps
Produit
Reactivity
Application
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human, Mouse, Rat
Application
WB, FACS, ELISA, IHC (p), ICC, IHC (fro), IF (p), IF (cc)
Validations
- (14)
- (12)
- (1)
N° du produit
ABIN1387847
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, IF, IP, IHC (p), ICC, IHC (wm)
Validations
- (10)
- (8)
N° du produit
ABIN2854751
Quantité
100 μL
Fiche technique
Fiche technique
Reactivity
Human
Application
WB, ELISA, IHC (p), PLA
Validations
- (1)
- (6)
N° du produit
ABIN560274
Quantité
100 μg
Fiche technique
Fiche technique
E-cadherin recommandé Kits ELISA
Produit
Reactivity
Analytical Method
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (2)
- (1)
N° du produit
ABIN6963429
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Human
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
- (1)
N° du produit
ABIN6954244
Quantité
96 tests
Fiche technique
Fiche technique
Reactivity
Rat
Analytical Method
Quantitative Sandwich ELISA
Validations
- (1)
N° du produit
ABIN6965292
Quantité
96 tests
Fiche technique
Fiche technique
E-cadherin recommandé Protéines
Produit
Reactivity
Source
Validations
N° du produit
Quantité
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1348882
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Wheat germ
Validations
- (1)
N° du produit
ABIN1348884
Quantité
10 μg
Fiche technique
Fiche technique
Reactivity
Human
Source
Escherichia coli (E. coli)
Validations
- (1)
N° du produit
ABIN7122069
Quantité
50 μg
Fiche technique
Fiche technique
Dernières publications sur nos produits E-cadherin
: "Personalized Approach to Determination of Histidine-Rich Glycoprotein and E-Cadherin in Supernatants of Immunocompetent Blood Cells and Breast Biopsy Specimens in Breast Malignant and Non-Malignant ..." dans: Doklady. Biochemistry and biophysics, Vol. 490, Issue 1, pp. 1-4, (2021) (PubMed).: "Characterization of the prognostic values and response to immunotherapy/chemotherapy of Krüppel-like factors in prostate cancer." dans: Journal of cellular and molecular medicine, Vol. 24, Issue 10, pp. 5797-5810, (2021) (PubMed).
: "38" dans: , Vol. 1363, Issue Nucleic acids research, pp. 28-39, (1991)
: "Loss of RE-1 silencing transcription factor accelerates exocrine damage from pancreatic injury." dans: Cell death & disease, Vol. 11, Issue 2, pp. 138, (2020) (PubMed).
: "Modulation of the dual-faced effects of miR-141 with chitosan/miR-141 nanoplexes in breast cancer cells." dans: The journal of gene medicine, Vol. 21, Issue 9, pp. e3116, (2020) (PubMed).
: "BST2 regulates interferon gamma-dependent decrease in invasion of HTR-8/SVneo cells via STAT1 and AKT signaling pathways and expression of E-cadherin." dans: Cell adhesion & migration, Vol. 14, Issue 1, pp. 24-41, (2020) (PubMed).
: "E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition." dans: Clinical and experimental nephrology, Vol. 23, Issue 8, pp. 1050-1057, (2020) (PubMed).
: "Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling." dans: Cells, Vol. 8, Issue 8, (2020) (PubMed).
: "Host restriction of Escherichia coli recurrent urinary tract infection occurs in a bacterial strain-specific manner." dans: PLoS pathogens, Vol. 14, Issue 12, pp. e1007457, (2019) (PubMed).
: "Deletion of Nrf2 enhances susceptibility to eosinophilic sinonasal inflammation in a murine model of rhinosinusitis." dans: International forum of allergy & rhinology, Vol. 9, Issue 1, pp. 114-119, (2019) (PubMed).
Synonymes et noms alternatifs relatifs à E-cadherin
cadherin 1 (CDH1), si:busm1-180o5.2 (si:busm1-180o5.2), cadherin 1, type 1, E-cadherin (epithelial) (cdh1), cadherin 1 (Cdh1), cadherin 1, type 1 S homeolog (cdh1.S), AA960649, Arc-1, arc-1, c-cadherin, cadherin-1, CD324, cd324, cdh1, cdhc-A, CDHE, cdhe, E-Cad, E-cad, E-cadherin, ECAD, ecad, Ecad, l-cam, L-CAM, LCAM, lcam, si:dz180o5.2, Um, UVO, uvo, uvomorulin, xb-cad, XB-cadherin, XBcad, xcdh1, XTCAD-1Protein level used designations for E-cadherin
- CAM 120/80
- E-Cadherin
- cadherin 1, E-cadherin (epithelial)
- cadherin-1
- calcium-dependent adhesion protein, epithelial
- cell-CAM 120/80
- epithelial cadherin
- uvomorulin
- hypothetical protein LOC368517
- cadherin 1, epithelial
- hab
- half baked
- E-cadherin
- cadherin 1, type 1, E-cadherin (epithelial)
- xTCAD-1
- ARC-1
- L-CAM
- liver cell adhesion molecule
- liver cell adhesion protein
- Epithelial cadherin
Avez-vous cherché autre chose?
Vous êtes ici:
